NCT07438977

Brief Summary

Periodontitis is a chronic inflammatory disease characterized by the progressive destruction of the supporting tissues of the teeth. Non-surgical periodontal therapy is the first-line treatment approach and aims to control inflammation and prevent further tissue breakdown. The aim of this interventional clinical study is to evaluate the effects of non-surgical periodontal therapy on serum levels of tartrate-resistant acid phosphatase 5b (TRACP-5b), bone alkaline phosphatase (BALP), and 25-hydroxyvitamin D3 in patients diagnosed with Stage III periodontitis. Patients with Stage III periodontitis will receive non-surgical periodontal therapy consisting of scaling and root planing. Clinical periodontal parameters and blood samples will be collected at baseline and after treatment. Changes in serum biomarker levels before and after therapy will be analyzed to assess the relationship between periodontal treatment and bone metabolism-related biomarkers. The findings of this study are expected to contribute to a better understanding of the systemic biochemical response to periodontal therapy in patients with advanced periodontitis.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 5, 2024

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

December 22, 2025

Completed
24 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 27, 2026

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2026

Completed
Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

1.1 years

First QC Date

December 22, 2025

Last Update Submit

February 23, 2026

Conditions

Keywords

Stage III periodontitisNon-surgical periodontal therapyScaling and root planingTRACP-5bBone alkaline phosphataseBone metabolism25-hydroxyvitamin D

Outcome Measures

Primary Outcomes (1)

  • Change in Serum TRACP-5b Level

    Change in serum tartrate-resistant acid phosphatase 5b (TRACP-5b) levels measured before and after non-surgical periodontal therapy.

    Baseline (pre-intervention) and Month 2 post-treatment

Secondary Outcomes (4)

  • Change in Probing Depth (PD)

    Baseline (pre-intervention) and Month 2 post-treatment

  • Change in Clinical Attachment Level (CAL)

    Baseline (pre-intervention) and Month 2 post-treatment

  • Change in Plaque Index (PI)

    Baseline (pre-intervention) and Month 2 post-treatment

  • Change in Gingival Index (GI)

    Baseline (pre-intervention) and Month 2 post-treatment

Other Outcomes (2)

  • Changes in Serum 25-Hydroxyvitamin D Level

    Baseline (pre-intervention) and Month 2 post-treatment

  • Change in Serum Bone Alkaline Phosphatase (BALP) Level

    Baseline (pre-intervention) and Month 2 post-treatment

Study Arms (1)

Non-Surgical Periodontal Therapy

EXPERIMENTAL

Participants with Stage III periodontitis receive non-surgical periodontal therapy consisting of scaling and root planing performed according to standard clinical protocols.

Procedure: Non-Surgical Periodontal Therapy

Interventions

Non-surgical periodontal therapy consisting of scaling and root planing performed using hand instruments and ultrasonic devices according to standard clinical protocols.

Also known as: Scaling and Root Planing
Non-Surgical Periodontal Therapy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 to 65 years
  • Diagnosed with Stage III periodontitis according to the current periodontal classification
  • Systemically healthy individuals
  • Presence of at least 20 natural teeth
  • Willingness to participate in the study and provide written informed consent

You may not qualify if:

  • Presence of systemic diseases that may affect periodontal status or bone metabolism
  • Use of antibiotics, anti-inflammatory drugs, or medications affecting bone metabolism within the last 3 months
  • Pregnancy or lactation
  • Current smokers or history of smoking
  • Previous periodontal treatment within the last 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atatürk University Faculty of Dentistry

Erzurum, Erzurum, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Periodontitis

Interventions

Tooth ExfoliationRoot Planing

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Dental Physiological PhenomenaDigestive System and Oral Physiological PhenomenaDental ScalingDental ProphylaxisPeriodonticsDentistrySubgingival CurettagePreventive Dentistry

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: This study uses a single-group, pre-post interventional design in which all participants receive non-surgical periodontal therapy, and clinical and biochemical outcomes are evaluated before and after treatment.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 22, 2025

First Posted

February 27, 2026

Study Start

December 5, 2024

Primary Completion

January 15, 2026

Study Completion

March 15, 2026

Last Updated

February 27, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to patient confidentiality considerations and the single-center design of the study.

Locations